Skip to content
Research Article Open access CC BY 4.0

Inflammatory Mediators (CA125, CRP) and Uric Acid in Association with Severity of Preeclampsia in North Kordofan State, Western Sudan

Naglaa Abdelbasit Suliman, Khidir Elamin Awadalla, Khalid Hussein Bakheit, Abdelrahim Osman Mohamed

International Journal of Biochemistry Research & Review · pp. 1–10 · Published 4 Nov 2022

10.9734/ijbcrr/2022/v31i10781

Abstract

Introduction: Inflammatory mediators could be laboratory markers of preeclampsia, as the induction of an inflammatory process within the placenta may trigger the expression of cancer antigen 125(CA125), C-reactive protein (CRP) and uric acid (UA). Regarding the pathophysiology of pre-eclampsia, there is defective trophoblastic invasion of uteroplacental blood vessels that leads to placental ischemia, and induction of an inflammatory process within the placenta. Objective: To evaluate the association of serum levels of cancer antigen (CA125), C-reactive protein (CRP) and serum uric acid with the Severity of Preeclampsia. Materials and Methods: The study recruited 200 singleton Sudanese pregnant women. These participants were divided into two groups: control (n = 100) and cases (n = 100). The cases were further subdivided into; mild preeclampsia (n =46), and severe preeclampsia (n = 54). The study groups were well-matched in maternal age, gestational age and body mass index. Blood samples were taken for measurement of serum cancer antigen-CA125, uric acid and C - reactive protein using immune- assay and enzymatic automated chemical analysis. Results: The mean levels of cancer antigen-CA125 in mild and severe preeclampsia groups were; 21.94±5.08 (IU/ml) and 40.77±9.82 (IU/ml) respectively, which were significantly higher, (P<0.001)   in comparison with the control group (16.88±7.36 (IU/ml). The mean levels of C-reactive protein in mild and severe preeclampsia were; 15.17±5.35 (mg/L), 31.49±12.56 (mg/L) respectively. There was significant difference in their levels, compared to the control group (4.79±1.78 (mg/L), (P<0.01).  Also, the mean levels of uric acid in mild and severe cases were; 6.44±1.98 and 7.37±2.00 which was significantly higher, in comparison with the control (4.00±0.61); (P<0.001). The level of uric acid also, showed significant difference within the case (severe and mild) group (P<0.05). CA125, CRP and UA level‎s correlated positively with Mean Arterial blood pressure (MAP), (r>0.7; P < 0.001). ROC curve validate the utility of these biomarker for the detection of preeclampsia severity (AUC>0. 8; P < 0.001). Conclusion: Serum cancer antigen 125(CA125), C- reactive protein and uric acid in studied preeclampsia groups were found to be significantly higher compared with the control group, and the rises were directly associated with the severity of preeclampsia.

Cancer antigen C-reactive protein uric acid preeclampsia (PE) Sudan

References (43)

  1. 1 Role of C-Reactive Protein at Sites of Inflammation and Infection [DOI]
  2. 2 Latest Advances in Understanding Preeclampsia [DOI]
  3. 3 Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention [DOI]
  4. 4 Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease? [DOI]
  5. 5 Hyperuricemia induces endothelial dysfunction [DOI]
  6. 6 The Two Stage Model of Preeclampsia: Variations on the Theme [DOI]
  7. 7 Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines [DOI]
  8. 8 The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP) [DOI]
  9. 9 Uric Acid as a Pathogenic Factor in Preeclampsia [DOI]
  10. 10 Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors [DOI]
  11. 11 Uric Acid Is as Important as Proteinuria in Identifying Fetal Risk in Women With Gestational Hypertension [DOI]
  12. 12 Pathophysiology of the Clinical Manifestations of Preeclampsia [DOI]
  13. 13 Preeclampsia: Pathogenesis, Prevention, and Long-Term Complications [DOI]
  14. 14 Hyperuricemia and endothelial function: From molecular background to clinical perspectives [DOI]
  15. 15 Pathophysiology of hypertension in pre‐eclampsia: a lesson in integrative physiology [DOI]
  16. 16 Serum tumor markers in the management of ovarian, endometrial and cervical cancer [DOI]
  17. 17 Advances in the pathophysiology of pre-eclampsia and related podocyte injury [DOI]
  18. 18 Renal function during normal pregnancy and preeclampsia [DOI]
  19. 19 Endothelial dysfunction in pre-eclampsia.
  20. 20 A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia [DOI]
  21. 21 Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia [DOI]
  22. 22 Uric acid, endothelial dysfunction and pre-eclampsia [DOI]
  23. 23 Could uric acid have a pathogenic role in pre-eclampsia? [DOI]
  24. 24 Association of fibrinogen and C-reactive protein with severity of preeclampsia [DOI]
  25. 25 Levels of C‐reactive protein in pregnant women who subsequently develop pre‐eclampsia [DOI]
  26. 26 Maternal Serum CA125 and CA15-3 Antigen Levels in Normal and Pathological Pregnancy [DOI]
  27. 27 Increased Serum Cancer Antigen-125 Is a Marker for Severity of Deep Endometriosis [DOI]
  28. 28 Association between Serum Uric Acid Levels and Perinatal Outcome in Women with Preeclampsia [DOI]
  29. 29 Human Peritoneal Mesothelial Cells Are More Potent Than Ovarian Cancer Cells in Producing Tumor Marker CA-125 [DOI]
  30. 30 CA-125 and CRP are Elevated in Preeclampsia [DOI]
  31. 31 Insulin Resistance and C-reactive Protein in Preeclampsia [DOI]
  32. 32 Association between serum CA125 levels in preeclampsia and its severity among women in Lagos, South-West Nigeria [DOI]
  33. 33 Tumor Markers in Hypertensive Disorders of Pregnancy [DOI]
  34. 34 Serum concentrations of CA-125 in normal and preeclamptic pregnancies [DOI]
  35. 35 Determination of cancer antigen-125 level and its association with preeclampsia among Sudanese women [DOI]
  36. 36 Uric Acid in Pregnancy and Preeclampsia: An Alternative Hypothesis [DOI]
  37. 37 Hyperhomocysteinemia in preeclampsia is associated to higher risk pressure profiles.
  38. 38 Serum CA‐125 levels in preeclampsia: A systematic review and meta‐analysis [DOI]
  39. 39 Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia [DOI]
  40. 40 Prediction of severity of preeclampsia in Egyptian patients: role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and C-reactive protein [DOI]
  41. 41 The association of serum Cancer antigen 125 and C-reactive protein level with the severity of preeclampsia
  42. 42 CA-125, plasma fibrinogen and C-reactive protein in correlation with severity of preeclampsia. [DOI]
  43. 43 "Serum Uric Acid and C-Reactive Protein in Preeclampsia" [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

43

Page views

0

PDF downloads

12

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.